benralizumab
FDA Approves Fasenra for Severe Eosinophilic Asthma
The FDA approved benralizumab for the add-on maintenance treatment of patients with severe eosinophilic phenotype ...
NOVEMBER 15, 2017

Load more
The FDA approved benralizumab for the add-on maintenance treatment of patients with severe eosinophilic phenotype ...
NOVEMBER 15, 2017